The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid
RecruitingNCT07017686Phase: NAStarted 2025-09
Summary
This open label clinical trial aims to assess the safety of abdominal vagus nerve stimulation (aVNS) for moderate to severe, adult-onset rheumatoid arthritis (RA) that has not responded to medication.
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
75 Years
Locations
Bionics InstituteFitzroy, Victoria, Australia
St Vincent's Hospital, Department of RheumatologyFitzroy, Victoria, Australia
Austin Health, Heidelberg Repatriation HospitalIvanhoe, Victoria, Australia
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07017686